Paper41316697
Electrophysiological diagnosis using the coefficient of variation of R-R intervals and a point-of-care nerve conduction device is highly correlated to the diagnosis of diabetic polyneuropathy using conventional electromyographs.
Himeno T and 14 others. J Diabetes Investig, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Electrophysiological diagnosis using the coefficient of variation of R-R intervals and a point-of-care nerve conduction device is highly correlated to the diagnosis of diabetic polyneuropathy using conventional electromyographs. Papers, record 41316697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41316697
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Electrophysiological diagnosis using the coefficient of variation of R-R intervals and a point-of-care nerve conduction device is highly correlated to the diagnosis of diabetic polyneuropathy using conventional electromyographs.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetic Neuropathies | Major topic |
| Electromyography | Major topic |
| Neural Conduction | Major topic |
| Point-of-Care Systems | Major topic |
| Humans | |
| Male | |
| Female | |
| Retrospective Studies | |
| Middle Aged | |
| Aged | |
| Adult | |
| Electrocardiography |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| JPMH20FA1701 | the Ministry of Health, Labour and Welfare | PubMed |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38422723 | Predictive value of heart rate variability and electrochemical skin conductance measurements for cardiovascular autonomic neuropathy persistence in type 2 diabetes and prediabetes: A 3-year follow-up study. | Neurophysiol Clin | 2024 | https://conductscience.org/library/papers/38422723 | PubMed |
| 2 | 9748012 | Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group. | Neurology | 1998 | https://conductscience.org/library/papers/9748012 | PubMed |
| 3 | 35562280 | Corneal confocal microscopy identifies small nerve fibre damage in patients with hypertriglyceridemia. | J Clin Lipidol | 2022 | https://conductscience.org/library/papers/35562280 | PubMed |
| 4 | 36201892 | Renal hemodynamic dysfunction and neuropathy in longstanding type 1 diabetes: Results from the Canadian study of longevity in type 1 diabetes. | J Diabetes Complications | 2022 | https://conductscience.org/library/papers/36201892 | PubMed |
| 5 | 16801576 | Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial. | Diabetes Care | 2006 | https://conductscience.org/library/papers/16801576 | PubMed |
| 6 | 33682297 | Impact of the metabolic syndrome on peripheral nerve structure and function in type 2 diabetes. | Eur J Neurol | 2021 | https://conductscience.org/library/papers/33682297 | PubMed |
| 7 | 11056593 | Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group. | JAMA | 2000 | https://conductscience.org/library/papers/11056593 | PubMed |
| 8 | 1838042 | The relationship between sural nerve morphometric findings and measures of peripheral nerve function in mild diabetic neuropathy. | Diabet Med | 1991 | https://conductscience.org/library/papers/1838042 | PubMed |
| 9 | 17065669 | Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. | Diabetes Care | 2006 | https://conductscience.org/library/papers/17065669 | PubMed |
| 10 | 24095132 | Diabetic autonomic neuropathy. | Handb Clin Neurol | 2013 | https://conductscience.org/library/papers/24095132 | PubMed |
| 11 | 7512429 | Nerve growth factor administration protects against experimental diabetic sensory neuropathy. | Brain Res | 1994 | https://conductscience.org/library/papers/7512429 | PubMed |
| 12 | 29098323 | Three-question set from Michigan Neuropathy Screening Instrument adds independent prognostic information on cardiovascular outcomes: analysis of ALTITUDE trial. | Diabetologia | 2018 | https://conductscience.org/library/papers/29098323 | PubMed |
| 13 | 21775755 | Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. | Diabetes Care | 2011 | https://conductscience.org/library/papers/21775755 | PubMed |
| 14 | 25802733 | A new Classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy. | J Diabetes Investig | 2015 | https://conductscience.org/library/papers/25802733 | PubMed |
| 15 | 8807467 | Clinical investigation of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy in Japan: multicenter study. Diabetic Neuropathy Study Group in Japan. | J Diabetes Complications | 1996 | https://conductscience.org/library/papers/8807467 | PubMed |
| 16 | 30603347 | Japanese Clinical Practice Guideline for Diabetes 2016. | Diabetol Int | 2018 | https://conductscience.org/library/papers/30603347 | PubMed |
| 17 | 8469345 | The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. | Neurology | 1993 | https://conductscience.org/library/papers/8469345 | PubMed |
| 18 | 38421109 | Simplified electrophysiological approach combining a point-of-care nerve conduction device and an electrocardiogram produces an accurate diagnosis of diabetic polyneuropathy. | J Diabetes Investig | 2024 | https://conductscience.org/library/papers/38421109 | PubMed |
| 19 | 11342572 | Reversal of experimental diabetic neuropathy by VEGF gene transfer. | J Clin Invest | 2001 | https://conductscience.org/library/papers/11342572 | PubMed |
| 20 | 31197183 | Diabetic neuropathy. | Nat Rev Dis Primers | 2019 | https://conductscience.org/library/papers/31197183 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42952199 | The low fasting serum C-peptide level was associated with reduced sural nerve action potential amplitudes: A cross-sectional study of Japanese type 2 diabetes. | J Diabetes Investig | 2026 | https://conductscience.org/library/papers/42952199 | PubMed |
| 42452461 | Direct Peroneal and Tibial Transcutaneous Electrical Nerve Stimulation for Improving Postural Control in European Women with Diabetic Polyneuropathy: A Randomized Controlled Trial. | J Clin Med | 2026 | https://conductscience.org/library/papers/42452461 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41316697
GET https://conductscience.org/api/papers/v1/41316697/references?page=2